Bo Feng
Impact in
- Pharmacology top 0.2%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Oncology top 1%
- Drug Transport and Resistance Mechanisms
Papers in
- Oncology 47
- Drug Transport and Resistance Mechanisms 45
-
- Pharmacological Effects and Toxicity Studies 29
- Co-authors
- Manthena V. S. Varma (18 shared papers)Matthew D. Troutman (7 shared papers)Li Di (7 shared papers)Haojing Rong (1 shared paper)Ralph E. Davidson (3 shared papers)Ayman El‐Kattan (7 shared papers)John Litchfield (5 shared papers)John Janiszewski (1 shared paper)
- Journals
- Drug Metabolism and Disposition (11 papers)Clinical Pharmacology & Therapeutics (6 papers)Journal of Pharmaceutical Sciences (5 papers)Annals of Nuclear Energy (4 papers)Molecular Pharmaceutics (3 papers)
- Partner nations
- United StatesUnited KingdomChina
In The Last Decade
Bo Feng
61 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 124
- Pharmacology 850
- Oncology 2.1k
- Pediatrics, Perinatology and Child Health 1.1k
- Biochemistry 200
- Neurology 157
Countries citing papers authored by Bo Feng
This map shows the geographic impact of Bo Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Feng more than expected).
Fields of papers citing papers by Bo Feng
This network shows the impact of papers produced by Bo Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Feng. The network helps show where Bo Feng may publish in the future.
Co-authors
The 25 scholars most cited alongside Bo Feng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 342 | |
| 2 | 2003 | 232 | |
| 3 | 2012 | 201 | |
| 4 | 2009 | 191 | |
| 5 | 2011 | 186 | |
| 6 | 2009 | 155 | |
| 7 | 2013 | 149 | |
| 8 | 2009 | 113 | |
| 9 | 2015 | 108 | |
| 10 | 2012 | 107 | |
| 11 | 2017 | 104 | |
| 12 | 2013 | 104 | |
| 13 | 2011 | 99 | |
| 14 | 2001 | 76 | |
| 15 | 2010 | 75 | |
| 16 | 2013 | 71 | |
| 17 | 2019 | 66 | |
| 18 | 2022 | 62 | |
| 19 | 2007 | 60 | |
| 20 | 2009 | 56 |
About Bo Feng
Bo Feng is a scholar working on Oncology, Pediatrics, Perinatology and Child Health, Pharmacology, Aerospace Engineering and Materials Chemistry, having authored 64 papers that have together received 3.4k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (45 papers), Pharmacological Effects and Toxicity Studies (29 papers), Pharmacogenetics and Drug Metabolism (13 papers), Nuclear reactor physics and engineering (10 papers), Nuclear Materials and Properties (9 papers), Drug-Induced Hepatotoxicity and Protection (6 papers), Metabolism and Genetic Disorders (5 papers) and HIV/AIDS drug development and treatment (5 papers). The work is most often cited by research in Pharmacology (850 citations), Oncology (2.1k citations), Pediatrics, Perinatology and Child Health (1.1k citations), Biochemistry (200 citations) and Neurology (157 citations). Bo Feng has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Manthena V. S. Varma, Matthew D. Troutman, Li Di, Haojing Rong, Ralph E. Davidson, Ayman El‐Kattan, John Litchfield, John Janiszewski, Sonia M. de Morais and Yurong Lai. Their work appears in journals such as Drug Metabolism and Disposition, Clinical Pharmacology & Therapeutics, Journal of Pharmaceutical Sciences, Annals of Nuclear Energy and Molecular Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.